chr10-122461729-G-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_002775.5(HTRA1):c.77G>A(p.Arg26Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00328 in 1,181,636 control chromosomes in the GnomAD database, including 85 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R26W) has been classified as Uncertain significance.
Frequency
Consequence
NM_002775.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
HTRA1 | NM_002775.5 | c.77G>A | p.Arg26Gln | missense_variant | 1/9 | ENST00000368984.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
HTRA1 | ENST00000368984.8 | c.77G>A | p.Arg26Gln | missense_variant | 1/9 | 1 | NM_002775.5 | P1 | |
HTRA1 | ENST00000648167.1 | c.154+3020G>A | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.0130 AC: 1924AN: 147674Hom.: 33 Cov.: 32
GnomAD3 exomes AF: 0.00407 AC: 185AN: 45490Hom.: 1 AF XY: 0.00479 AC XY: 132AN XY: 27552
GnomAD4 exome AF: 0.00189 AC: 1950AN: 1033854Hom.: 53 Cov.: 30 AF XY: 0.00202 AC XY: 1019AN XY: 503432
GnomAD4 genome AF: 0.0131 AC: 1929AN: 147782Hom.: 32 Cov.: 32 AF XY: 0.0127 AC XY: 913AN XY: 72018
ClinVar
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Sep 12, 2017 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 24, 2024 | - - |
Macular degeneration Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at